Versor Investments’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Versor Investments’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-268,019	Closed	-$10.1M	–	421
2021 Q1	$10.1M	Buy	+268,019	New	+$6.68M	0.6%	29

Versor Investments's FPRX Position: Q2 2021 in Review

Versor Investments sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 268,019 shares — an estimated $10.1M sold.

Versor Investments first reported a position in FPRX in Q1 2021 and held it in 1 quarter. The position peaked at $10.1M in Q1 2021. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.

Versor Investments reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
Versor Investments sold 268,019 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $10.1M.
Versor Investments first reported a position in Five Prime Therapeutics, Inc. in Q1 2021 and held it in 1 quarter.
Versor Investments's Five Prime Therapeutics, Inc. position peaked at $10.1M in Q1 2021.
0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.

Based on Versor Investments's 13F filing for Q2 2021, filed 27 Jul 2021.